Pharma M&A versus alliances and its underlying value drivers

Pharma M&A versus alliances and its underlying value drivers

for $ 62.95 , or download a preview

62.95 Pharma M&A versus alliances and its underlying value drivers https://covers.feedbooks.net/item/2544751.jpg?t=1547424432 http://www.feedbooks.com/item/2544751/pharma-m-amp-a-versus-alliances-and-its-underlying-value-drivers?utm_medium=uwishlist&utm_source=amazon

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant… (more)